Table B4.
New studies published after last search.
| Exposure | Study | Country | Cohort | Study population | Follow up period | Outcome | HR (95%CI) |
|---|---|---|---|---|---|---|---|
| NO2 | Hanigan 2019 | Australia | 45 and Up | General population | 2007–2015 | All cause | 1.03 (0.98, 1.07) |
| Hvidtfeldt 2019 | Denmark | Danish Diet, Cancer and Health | General population | 1993–2015 | All cause | 1.05 (1.01, 1.09) | |
| Respiratory | 1.03 (0.97, 1.09) | ||||||
| Klompmaker 2020 | Netherlands | Dutch National Health Survey | General population | 2013–2017 | All cause | 0.99 (0.97, 1.01) | |
| Respiratory | 0.98 (0.91, 1.06) | ||||||
| Lim 2019 | US | NIH-AARP | General population | 1995–2011 | All cause | 1.04 (1.02, 1.05) | |
| Respiratory | 1.04 (0.99, 1.08) | ||||||
| COPD | 1.03 (0.98, 1.08) | ||||||
| ALRI | 1.22 (1.11, 1.35) | ||||||
| O3(Annual) | Hvidtfeldt 2019 | Denmark | Danish Diet, Cancer and Health | General population | 1993–2015 | All cause | 0.95 (0.91, 1.00) |
| Respiratory | 0.97 (0.89, 1.05) | ||||||
| Lim 2019 | US | NIH-AARP | General population | 1995–2011 | All cause | 0.99 (0.98, 1.00) | |
| Respiratory | 1.04 (1.00, 1.09) | ||||||
| COPD | 1.09 (1.03, 1.15) | ||||||
| ALRI | 1.00 (0.90, 1.11) | ||||||
| O3(Warm season) | Lim 2019 | US | NIH-AARP | General population | 1995–2011 | All cause | 1.00 (0.99, 1.01) |
| Respiratory | 1.04 (1.02, 1.06) | ||||||
| COPD | 1.05 (1.02, 1.08) | ||||||
| ALRI | 1.05 (0.99, 1.10) | ||||||
| Kazemiparkouhi 2019 | US | Medicare beneficiaries | General population | 2000–2008 | All cause | 1.013 (1.012, 1.014) | |
| Respiratory | 1.036 (1.032, 1.039) | ||||||
| COPD | 1.065 (1.060, 1.069) |